JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB176568

Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal

Be the first to review this product! Submit a review

|

(10 Publications)

Rabbit Recombinant Monoclonal UBE2D3 antibody. N-terminal. Suitable for IP, WB and reacts with Human samples. Cited in 10 publications.

View Alternative Names

UBC5C, UBCH5C, UBE2D3, Ubiquitin-conjugating enzyme E2 D3, (E3-independent) E2 ubiquitin-conjugating enzyme D3, E2 ubiquitin-conjugating enzyme D3, Ubiquitin carrier protein D3, Ubiquitin-conjugating enzyme E2(17)KB 3, Ubiquitin-conjugating enzyme E2-17 kDa 3, Ubiquitin-protein ligase D3

3 Images
Immunoprecipitation - Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal (AB176568)
  • IP

Supplier Data

Immunoprecipitation - Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal (AB176568)

Western blot analysis on immunoprecipitation pellet from 293T cell lysate labeling UBE2D3 with ab176568 at 1/10 dilution.

All lanes:

Immunoprecipitation - Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal (ab176568)

Predicted band size: 16 kDa

true

Western blot - Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal (AB176568)
  • WB

Supplier Data

Western blot - Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal (AB176568)

All lanes:

Western blot - Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal (ab176568) at 1/1000 dilution

Lane 1:

MCF7 cell lysate at 10 µg

Lane 2:

Jurkat cell lysate at 10 µg

Lane 3:

293T cell lysate at 10 µg

Secondary

All lanes:

Goat anti-rabbit HRP at 1/2000 dilution

Predicted band size: 16 kDa

true

Western blot - Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal (AB176568)
  • WB

CiteAb

Western blot - Anti-UBE2D3 antibody [EPR13001(B)] - N-terminal (AB176568)

UBE2D3 western blot using anti-UBE2D3 antibody [EPR13001(B)] - N-terminal ab176568. Publication image and figure legend from Shi, Y., Yuan, B., et al., 2017, Nat Commun, PubMed 28469175.

ab176568 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab176568 please see the product overview.

Ub2D3 and Ube2N are required for RIG-I and MAVS activation on virus infection in HEK293T cells.(a,b) The cell-free assay containing vRNA and purified components (E1, Ub, RIG-I and Riplet) was performed as described in Fig. 2b, except that S100 fraction was substituted with purified E2 recombinant proteins as indicated. Each E2 protein was analysed at three different concentrations. Lane 13 did not contain E2 proteins (-E2). (c) HEK293T cells (wild-type and knockout lines) were transfected with or without si-Ube2D3 RNAs. Seventy two hours after transfection, the cells were infected with VSV. Twelve hours post virus infection, the cells were collected for measuring IFN induction by qPCR. *p<0.05 and ***p<0.001. (d,e) Cells were treated as described in c. P5 fractions were isolated to examine MAVS aggregation (d), and whole cell lysate were used to analyse knockdown or knockout effect in genes as indicated (e). The original full blot for (e) can be found in Supplementary Fig. 8d. (f) si-Ube2D3 RNAs were transfected into HEK293T (Ube2N-/-) cells. Seventy two hours after siRNA transfection, the cells were further transfected with pcDNA-flag-Ube2D3 or pcDNA-flag-Ube2N as indicated. Twenty four hours after transfection of pcDNA plasmids, the cells were infected with VSV for another twelve hours. The cells were then collected for analysis of MAVS aggregation. See also Supplementary Fig. 3f.

false

  • Carrier free

    Anti-UBE2D3 antibody [EPR13001(B)] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR13001(B)

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

The immunogen used for this product shares 6 continuous identical amino acids with UBE2D1,UBE2D2 and UBE2D4.  Cross-reactivity with these proteins have not been confirmed experimentally.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/10 - 1/100", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

UBE2D3 also known as UbcH5c or E2-17k is a ubiquitin-conjugating enzyme. It plays a critical role in the ubiquitination process by interacting with ligase enzymes adding ubiquitin to target proteins. This protein has a molecular mass of approximately 16 kDa. UBE2D3 is widely expressed in various tissues indicating its role in several cellular functions.
Biological function summary

UBE2D3 acts as an important component in protein degradation and regulation. It participates in the ubiquitin-proteasome system which controls protein levels in cells. UBE2D3 forms part of larger protein complexes such as the SCF (Skp Cullin F-box containing) complex contributing to the regulation of cell cycle and signal transduction. This interaction helps control cell division and response to external signals.

Pathways

UBE2D3 plays an important role in the NF-kB signaling and DNA damage response pathways. It interacts with proteins such as IKK (IκB kinase) to regulate inflammation and immune response. Additionally UBE2D3's involvement in the DNA repair pathway supports maintaining genome stability by collaborating with other proteins like BRCA1 which is essential for repairing DNA double-strand breaks.

UBE2D3 shows a connection to cancer and neurodegenerative diseases. Its role in the NF-kB signaling pathway links it to cancer development due to its regulation of genes involved in cell growth and survival. In neurodegenerative disorders such as Alzheimer's disease abnormal ubiquitination due to UBE2D3 dysfunction may lead to protein aggregation affecting normal cellular activities. Its interaction with proteins like p53 a well-known tumor suppressor illustrates its importance in disease progression and regulation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins (PubMed : 15247280, PubMed : 15496420, PubMed : 18284575, PubMed : 20061386, PubMed : 21532592, PubMed : 28322253). In vitro catalyzes 'Lys-11'-, as well as 'Lys-48'-linked polyubiquitination (PubMed : 15247280, PubMed : 15496420, PubMed : 18284575, PubMed : 20061386, PubMed : 21532592). Cooperates with the E2 CDC34 and the SCF(FBXW11) E3 ligase complex for the polyubiquitination of NFKBIA leading to its subsequent proteasomal degradation (PubMed : 20347421). Acts as an initiator E2, priming the phosphorylated NFKBIA target at positions 'Lys-21' and/or 'Lys-22' with a monoubiquitin (PubMed : 10329681). Ubiquitin chain elongation is then performed by CDC34, building ubiquitin chains from the UBE2D3-primed NFKBIA-linked ubiquitin (PubMed : 10329681). Acts also as an initiator E2, in conjunction with RNF8, for the priming of PCNA (PubMed : 18948756). Monoubiquitination of PCNA, and its subsequent polyubiquitination, are essential events in the operation of the DNA damage tolerance (DDT) pathway that is activated after DNA damage caused by UV or chemical agents during S-phase (PubMed : 18948756). Associates with the BRCA1/BARD1 E3 ligase complex to perform ubiquitination at DNA damage sites following ionizing radiation leading to DNA repair (PubMed : 16628214). Targets DAPK3 for ubiquitination which influences promyelocytic leukemia protein nuclear body (PML-NB) formation in the nucleus (PubMed : 18515077). In conjunction with the MDM2 and TOPORS E3 ligases, functions ubiquitination of p53/TP53 (PubMed : 12646252, PubMed : 15280377). In conjunction with the CBL E3 ligase, targets EGFR for polyubiquitination at the plasma membrane as well as during its internalization and transport on endosomes (PubMed : 18508924). In conjunction with the STUB1 E3 quality control E3 ligase, ubiquitinates unfolded proteins to catalyze their immediate destruction (PubMed : 11743028). Together with RNF135, catalyzes the viral RNA-dependent 'Lys-63'-linked polyubiquitination of RIGI to activate the downstream signaling pathway that leads to interferon beta production (PubMed : 28469175). Together with ZNF598, catalyzes ubiquitination of 40S ribosomal proteins in response to ribosome collisions (PubMed : 28685749). In cooperation with the GATOR2 complex, catalyzes 'Lys-6'-linked ubiquitination of NPRL2 (PubMed : 36528027).
See full target information UBE2D3

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:7359 PubMed39198387

2024

Inhibition of TOPORS ubiquitin ligase augments the efficacy of DNA hypomethylating agents through DNMT1 stabilization.

Applications

Unspecified application

Species

Unspecified reactive species

Satoshi Kaito,Kazumasa Aoyama,Motohiko Oshima,Akiho Tsuchiya,Makiko Miyota,Masayuki Yamashita,Shuhei Koide,Yaeko Nakajima-Takagi,Hiroko Kozuka-Hata,Masaaki Oyama,Takao Yogo,Tomohiro Yabushita,Ryoji Ito,Masaya Ueno,Atsushi Hirao,Kaoru Tohyama,Chao Li,Kimihito Cojin Kawabata,Kiyoshi Yamaguchi,Yoichi Furukawa,Hidetaka Kosako,Akihide Yoshimi,Susumu Goyama,Yasuhito Nannya,Seishi Ogawa,Karl Agger,Kristian Helin,Satoshi Yamazaki,Haruhiko Koseki,Noriko Doki,Yuka Harada,Hironori Harada,Atsuya Nishiyama,Makoto Nakanishi,Atsushi Iwama

The EMBO journal 43:1089-1109 PubMed38360992

2024

Structural insights into the ubiquitylation strategy of the oligomeric CRL2 E3 ubiquitin ligase.

Applications

Unspecified application

Species

Unspecified reactive species

Zonglin Dai,Ling Liang,Weize Wang,Peng Zuo,Shang Yu,Yaqi Liu,Xuyang Zhao,Yishuo Lu,Yan Jin,Fangting Zhang,Dian Ding,Weiwei Deng,Yuxin Yin

Molecular medicine (Cambridge, Mass.) 29:162 PubMed38041015

2023

The linear ANRIL transcript P14AS regulates the NF-κB signaling to promote colon cancer progression.

Applications

Unspecified application

Species

Unspecified reactive species

Wanru Ma,Junhua Hu

ACS chemical biology 18:897-904 PubMed36940189

2023

Targeted Protein Degradation through E2 Recruitment.

Applications

Unspecified application

Species

Unspecified reactive species

Nafsika Forte,Dustin Dovala,Matthew J Hesse,Jeffrey M McKenna,John A Tallarico,Markus Schirle,Daniel K Nomura

Cell chemical biology 30:394-402.e9 PubMed36898369

2023

Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-κB.

Applications

Unspecified application

Species

Unspecified reactive species

Elizabeth A King,Yoojin Cho,Nathan S Hsu,Dustin Dovala,Jeffrey M McKenna,John A Tallarico,Markus Schirle,Daniel K Nomura

Frontiers in oncology 11:674286 PubMed34195079

2021

UBE2D3 Activates SHP-2 Ubiquitination to Promote Glycolysis and Proliferation of Glioma Regulating STAT3 Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenjiang Pan,Jing Bao,Liujun Zhang,Shepeng Wei

Frontiers in cell and developmental biology 9:667435 PubMed33996822

2021

The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance.

Applications

Unspecified application

Species

Unspecified reactive species

Meng-Ge Du,Zhi-Qiang Peng,Wen-Bin Gai,Fan Liu,Wei Liu,Yu-Jiao Chen,Hong-Chang Li,Xin Zhang,Cui Hua Liu,Ling-Qiang Zhang,Hong Jiang,Ping Xie

Nature communications 8:15138 PubMed28469175

2017

Ube2D3 and Ube2N are essential for RIG-I-mediated MAVS aggregation in antiviral innate immunity.

Applications

WB

Species

Human

Yuheng Shi,Bofeng Yuan,Wenting Zhu,Rui Zhang,Lin Li,Xiaojing Hao,She Chen,Fajian Hou

Journal of immunology (Baltimore, Md. : 1950) 198:820-831 PubMed27986908

2016

A20 Ameliorates Intracerebral Hemorrhage-Induced Inflammatory Injury by Regulating TRAF6 Polyubiquitination.

Applications

Unspecified application

Species

Unspecified reactive species

Zhaoyou Meng,Ting Zhao,Kai Zhou,Qi Zhong,Yanchun Wang,Xiaoyi Xiong,Faxiang Wang,Yuanrui Yang,Wenyao Zhu,Juan Liu,Maofan Liao,Lirong Wu,Chunmei Duan,Jie Li,Qiuwen Gong,Liang Liu,Ao Xiong,Meihua Yang,Jian Wang,Qingwu Yang

Journal of Cancer 7:1152-62 PubMed27326259

2016

Downregulation of Ubiquitin-conjugating Enzyme UBE2D3 Promotes Telomere Maintenance and Radioresistance of Eca-109 Human Esophageal Carcinoma Cells.

Applications

WB

Species

Unspecified reactive species

Hui Yang,Lin Wu,Shaobo Ke,Wenbo Wang,Lei Yang,Xiaojia Gao,Hongyan Fang,Haijun Yu,Yahua Zhong,Conghua Xie,Fuxiang Zhou,Yunfeng Zhou
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com